Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Dec 17;159(12):806-14.
doi: 10.7326/0003-4819-159-12-201312170-00006.

Long-term multivitamin supplementation and cognitive function in men: a randomized trial

Francine Grodstein, Jacqueline O'Brien, Jae Hee Kang, Rimma Dushkes, Nancy R Cook, Olivia Okereke, JoAnn E Manson, Robert J Glynn, Julie E Buring, Michael Gaziano, Howard D Sesso
Randomized Controlled Trial

Long-term multivitamin supplementation and cognitive function in men: a randomized trial

Francine Grodstein et al. Ann Intern Med. .

Abstract

Background: Despite widespread use of multivitamin supplements, their effect on cognitive health-a critical issue with aging-remains inconclusive. To date, no long-term clinical trials have studied multivitamin use and cognitive decline in older persons.

Objective: To evaluate whether long-term multivitamin supplementation affects cognitive health in later life.

Design: Randomized, double-blind, placebo-controlled trial of a multivitamin from 1997 to 1 June 2011. The cognitive function substudy began in 1998. Up to 4 repeated cognitive assessments by telephone interview were completed over 12 years. (ClinicalTrials.gov: NCT00270647) SETTING: The Physicians' Health Study II.

Patients: 5947 male physicians aged 65 years or older.

Intervention: Daily multivitamin or placebo.

Measurements: A global composite score averaging 5 tests of global cognition, verbal memory, and category fluency. The secondary end point was a verbal memory score combining 4 tests of verbal memory, which is a strong predictor of Alzheimer disease.

Results: No difference was found in mean cognitive change over time between the multivitamin and placebo groups or in the mean level of cognition at any of the 4 assessments. Specifically, for the global composite score, the mean difference in cognitive change over follow-up was -0.01 SU (95% CI, -0.04 to 0.02 SU) when treatment was compared with placebo. Similarly, cognitive performance did not differ between the multivitamin and placebo groups on the secondary outcome, verbal memory (mean difference in cognitive change over follow-up, -0.005 SU [CI, -0.04 to 0.03 SU]).

Limitation: Doses of vitamins may be too low or the population may be too well-nourished to benefit from a multivitamin.

Conclusion: In male physicians aged 65 years or older, long-term use of a daily multivitamin did not provide cognitive benefits.

Primary funding source: National Institutes of Health, BASF, Pfizer, and DSM Nutritional Products.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of participants in the cognitive substudy of the Physicians’ Health Study II (PHS II).
See this image and copyright information in PMC

Comment in

Summary for patients in

References

    1. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol. 2000;57(6):839–44. - PubMed
    1. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141(2):261–6. - PMC - PubMed
    1. Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, et al. Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2012;308(18):1871–80. - PMC - PubMed
    1. Rosenberg IH. Challenges and opportunities in the translation of the science of vitamins. Am J Clin Nutr. 2007;85(1):325S–7S. - PubMed
    1. Kennedy DO, Haskell CF. Vitamins and cognition: what is the evidence? Drugs. 2011;71(15):1957–71. - PubMed

Publication types

Associated data